Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer
Background Pancreatic cancer (PAC) is one of the most malignant cancer types and immunotherapy has emerged as a promising treatment option. PAC cells undergo metabolic reprogramming, which is thought to modulate the tumor microenvironment (TME) and affect immunotherapy outcomes. However, the metabol...
Saved in:
| Main Authors: | Yang Song, Cheng Yang, Jie Min, Lei Hua, Haichuan Su, Ting Zhao, Yongdong Guo, Ronglin Wang, Jingjie Shi, Peixiang Ma, Junqiang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-09-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/9/e007466.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice
by: Qian Li, et al.
Published: (2025-07-01) -
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer
by: Hanshen Yang, et al.
Published: (2025-08-01) -
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors
by: Liaoliao Zhu, et al.
Published: (2025-05-01) -
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
by: Yi Lin, et al.
Published: (2020-10-01) -
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
by: Deborah Collyar, et al.
Published: (2025-03-01)